Annual Working Capital
$279.43 M
-$198.33 M-41.51%
31 December 2023
Summary:
Nektar Therapeutics annual working capital is currently $279.43 million, with the most recent change of -$198.33 million (-41.51%) on 31 December 2023. During the last 3 years, it has fallen by -$742.79 million (-72.66%). NKTR annual working capital is now -79.39% below its all-time high of $1.36 billion, reached on 31 December 2018.NKTR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$218.90 M
-$18.96 M-7.97%
30 September 2024
Summary:
Nektar Therapeutics quarterly working capital is currently $218.90 million, with the most recent change of -$18.96 million (-7.97%) on 30 September 2024. Over the past year, it has dropped by -$128.01 million (-36.90%). NKTR quarterly working capital is now -87.90% below its all-time high of $1.81 billion, reached on 30 June 2018.NKTR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.5% | -36.9% |
| 3 y3 years | -72.7% | -74.1% |
| 5 y5 years | -79.4% | -84.9% |
NKTR Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -72.7% | at low | -74.1% | at low |
| 5 y | 5 years | -79.4% | at low | -84.9% | at low |
| alltime | all time | -79.4% | >+9999.0% | -87.9% | >+9999.0% |
Nektar Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $218.90 M(-8.0%) |
| June 2024 | - | $237.86 M(-11.1%) |
| Mar 2024 | - | $267.43 M(-4.3%) |
| Dec 2023 | $279.43 M(-41.5%) | $279.43 M(-19.5%) |
| Sept 2023 | - | $346.91 M(-11.1%) |
| June 2023 | - | $390.36 M(-9.5%) |
| Mar 2023 | - | $431.19 M(-9.7%) |
| Dec 2022 | $477.76 M(-32.7%) | $477.76 M(-7.3%) |
| Sept 2022 | - | $515.49 M(-8.0%) |
| June 2022 | - | $560.55 M(-10.8%) |
| Mar 2022 | - | $628.17 M(-11.6%) |
| Dec 2021 | $710.38 M(-30.5%) | $710.38 M(-16.0%) |
| Sept 2021 | - | $846.17 M(-8.5%) |
| June 2021 | - | $925.13 M(-5.2%) |
| Mar 2021 | - | $975.42 M(-4.6%) |
| Dec 2020 | $1.02 B(-4.3%) | $1.02 B(+11.4%) |
| Sept 2020 | - | $917.36 M(-10.8%) |
| June 2020 | - | $1.03 B(-2.3%) |
| Mar 2020 | - | $1.05 B(-1.5%) |
| Dec 2019 | $1.07 B(-21.2%) | $1.07 B(-26.5%) |
| Sept 2019 | - | $1.45 B(-2.0%) |
| June 2019 | - | $1.48 B(+6.7%) |
| Mar 2019 | - | $1.39 B(+2.6%) |
| Dec 2018 | $1.36 B(+400.9%) | $1.36 B(-3.0%) |
| Sept 2018 | - | $1.40 B(-22.8%) |
| June 2018 | - | $1.81 B(+608.5%) |
| Mar 2018 | - | $255.32 M(-5.7%) |
| Dec 2017 | $270.66 M(-23.5%) | $270.66 M(-6.8%) |
| Sept 2017 | - | $290.25 M(+34.7%) |
| June 2017 | - | $215.55 M(-28.7%) |
| Mar 2017 | - | $302.47 M(-14.5%) |
| Dec 2016 | $353.73 M(+22.5%) | $353.73 M(+71.5%) |
| Sept 2016 | - | $206.22 M(-13.7%) |
| June 2016 | - | $239.04 M(-14.3%) |
| Mar 2016 | - | $278.90 M(-3.4%) |
| Dec 2015 | $288.81 M(+28.8%) | $288.81 M(+269.1%) |
| Sept 2015 | - | $78.25 M(-64.6%) |
| June 2015 | - | $221.17 M(-18.6%) |
| Mar 2015 | - | $271.85 M(+21.3%) |
| Dec 2014 | $224.15 M(+40.4%) | $224.15 M(-8.0%) |
| Sept 2014 | - | $243.57 M(+13.9%) |
| June 2014 | - | $213.87 M(-5.1%) |
| Mar 2014 | - | $225.46 M(+41.2%) |
| Dec 2013 | $159.66 M(-32.4%) | $159.66 M(+25.7%) |
| Sept 2013 | - | $127.03 M(-11.9%) |
| June 2013 | - | $144.15 M(-21.6%) |
| Mar 2013 | - | $183.81 M(-22.1%) |
| Dec 2012 | $236.09 M(>+9900.0%) | $236.09 M(-14.9%) |
| Sept 2012 | - | $277.48 M(+44.9%) |
| June 2012 | - | $191.43 M(+27.7%) |
| Mar 2012 | - | $149.90 M(>+9900.0%) |
| Dec 2011 | $1.17 M(-99.6%) | $1.17 M(-93.7%) |
| Sept 2011 | - | $18.58 M(-94.3%) |
| June 2011 | - | $327.82 M(-31.8%) |
| Mar 2011 | - | $480.49 M(+65.8%) |
| Dec 2010 | $289.87 M(+11.2%) | $289.87 M(+20.0%) |
| Sept 2010 | - | $241.60 M(-5.7%) |
| June 2010 | - | $256.34 M(-1.3%) |
| Mar 2010 | - | $259.83 M(-0.3%) |
| Dec 2009 | $260.65 M | $260.65 M(+4.7%) |
| Sept 2009 | - | $248.86 M(-8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $272.89 M(-10.2%) |
| Mar 2009 | - | $303.96 M(-10.0%) |
| Dec 2008 | $337.85 M(-20.5%) | $337.85 M(-6.6%) |
| Sept 2008 | - | $361.76 M(+3.0%) |
| June 2008 | - | $351.37 M(-8.9%) |
| Mar 2008 | - | $385.88 M(-9.2%) |
| Dec 2007 | $425.19 M(+15.0%) | $425.19 M(+18.7%) |
| Sept 2007 | - | $358.09 M(-1.1%) |
| June 2007 | - | $362.04 M(-4.8%) |
| Mar 2007 | - | $380.10 M(+2.8%) |
| Dec 2006 | $369.73 M(-17.9%) | $369.73 M(-18.0%) |
| Sept 2006 | - | $451.10 M(-1.5%) |
| June 2006 | - | $457.89 M(+4.3%) |
| Mar 2006 | - | $439.06 M(-2.5%) |
| Dec 2005 | $450.25 M(+12.9%) | $450.25 M(-26.2%) |
| Sept 2005 | - | $610.38 M(+71.1%) |
| June 2005 | - | $356.74 M(-5.5%) |
| Mar 2005 | - | $377.36 M(-5.4%) |
| Dec 2004 | $398.89 M(+53.6%) | $398.89 M(-3.3%) |
| Sept 2004 | - | $412.29 M(-0.9%) |
| June 2004 | - | $416.05 M(-5.5%) |
| Mar 2004 | - | $440.24 M(+69.6%) |
| Dec 2003 | $259.64 M(+5.0%) | $259.64 M(-6.6%) |
| Sept 2003 | - | $278.04 M(-2.4%) |
| June 2003 | - | $284.76 M(+24.2%) |
| Mar 2003 | - | $229.31 M(-7.3%) |
| Dec 2002 | $247.32 M(-18.0%) | $247.32 M(-11.2%) |
| Sept 2002 | - | $278.49 M(-6.1%) |
| June 2002 | - | $296.45 M(-5.8%) |
| Mar 2002 | - | $314.79 M(+4.4%) |
| Dec 2001 | $301.64 M(-34.8%) | $301.64 M(-7.1%) |
| Sept 2001 | - | $324.54 M(-5.4%) |
| June 2001 | - | $342.94 M(-19.4%) |
| Mar 2001 | - | $425.43 M(-8.1%) |
| Dec 2000 | $462.84 M(+278.6%) | $462.84 M(+73.3%) |
| Sept 2000 | - | $267.13 M(-6.8%) |
| June 2000 | - | $286.65 M(-8.2%) |
| Mar 2000 | - | $312.33 M(+155.5%) |
| Dec 1999 | $122.24 M(+70.3%) | $122.24 M(+152.4%) |
| Sept 1999 | - | $48.44 M(-14.8%) |
| June 1999 | - | $56.83 M(-8.6%) |
| Mar 1999 | - | $62.15 M(-13.4%) |
| Dec 1998 | $71.78 M(-14.4%) | $71.78 M(+32.5%) |
| Sept 1998 | - | $54.17 M(-14.7%) |
| June 1998 | - | $63.48 M(-12.3%) |
| Mar 1998 | - | $72.34 M(-13.7%) |
| Dec 1997 | $83.81 M(+167.8%) | $83.81 M(+68.5%) |
| Sept 1997 | - | $49.74 M(-10.1%) |
| June 1997 | - | $55.34 M(-6.9%) |
| Mar 1997 | - | $59.46 M(+90.0%) |
| Dec 1996 | $31.30 M(+76.8%) | $31.30 M(+5.0%) |
| Sept 1996 | - | $29.80 M(-8.0%) |
| June 1996 | - | $32.40 M(+106.4%) |
| Mar 1996 | - | $15.70 M(-11.3%) |
| Dec 1995 | $17.70 M(+32.1%) | $17.70 M(-11.1%) |
| Sept 1995 | - | $19.90 M(-8.3%) |
| June 1995 | - | $21.70 M(-7.7%) |
| Mar 1995 | - | $23.50 M(+75.4%) |
| Dec 1994 | $13.40 M | $13.40 M(-15.2%) |
| Sept 1994 | - | $15.80 M(-10.2%) |
| June 1994 | - | $17.60 M(+351.3%) |
| Mar 1994 | - | $3.90 M |
FAQ
- What is Nektar Therapeutics annual working capital?
- What is the all time high annual working capital for Nektar Therapeutics?
- What is Nektar Therapeutics annual working capital year-on-year change?
- What is Nektar Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly working capital year-on-year change?
What is Nektar Therapeutics annual working capital?
The current annual working capital of NKTR is $279.43 M
What is the all time high annual working capital for Nektar Therapeutics?
Nektar Therapeutics all-time high annual working capital is $1.36 B
What is Nektar Therapeutics annual working capital year-on-year change?
Over the past year, NKTR annual working capital has changed by -$198.33 M (-41.51%)
What is Nektar Therapeutics quarterly working capital?
The current quarterly working capital of NKTR is $218.90 M
What is the all time high quarterly working capital for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly working capital is $1.81 B
What is Nektar Therapeutics quarterly working capital year-on-year change?
Over the past year, NKTR quarterly working capital has changed by -$128.01 M (-36.90%)